Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2005
10/20/2005WO2005098429A2 System and method for real-time diagnosis, treatment, and therapeutic drug monitoring
10/20/2005WO2005098428A2 Method and system for screening compounds for muscular and/or neurological activity in animals
10/20/2005WO2005098427A2 Method, composition and device for treating starch related diseases
10/20/2005WO2005098426A1 Skin sensitivity test device and method
10/20/2005WO2005098425A1 Non-invasive, in vitro functional tissue assay systems
10/20/2005WO2005098424A1 Method and apparatus for implementing threshold based correction functions for biosensors
10/20/2005WO2005098423A1 Multiwell plate assembly for use in high throughput assays
10/20/2005WO2005098422A2 Detecting recessive diseases in inbred populations
10/20/2005WO2005098421A2 Sensor for contaminants
10/20/2005WO2005098420A1 Geomorphology for environmental remediation processes and systems
10/20/2005WO2005098419A1 Measuring device which is used to measure the state of oils or fats
10/20/2005WO2005098418A1 A novel visual colorimetric reagent for the rapid estimation of fluoride in ground water
10/20/2005WO2005098414A1 Methods for detecting 14-hydroxycodeinone and codeinone
10/20/2005WO2005098412A2 Multicomponent analysis of volatile organic compositions in vapor samples
10/20/2005WO2005098410A1 Gas probe with hygroscopic coated protection device
10/20/2005WO2005098407A1 Measuring device for measuring the state of oils or fats
10/20/2005WO2005098406A1 Measuring device which is used to measure the state of oils or fats
10/20/2005WO2005098396A2 High-density ion transport measurement biochip devices and methods
10/20/2005WO2005098391A1 Active sampler for detecting contaminants in liquids
10/20/2005WO2005098377A1 Instruments, related systems, and methods for monitoring or controlling foaming
10/20/2005WO2005098051A2 Hsv-2 type-specific immunoassays using glycoprotein g2 peptides
10/20/2005WO2005098045A1 Diagnosis of systemic lupus erythematosus
10/20/2005WO2005098039A2 Method and apparatus for analyzing and generating human antibody amino acid and nucleic acid sequences
10/20/2005WO2005098026A1 Method of determining carbonic anhydrase i activity
10/20/2005WO2005098024A1 In vivo measurement of the relative fluxes through ribonucleotide reductase vs. deoxyribonucleoside pathways using isotopes
10/20/2005WO2005098020A1 Assay method for determining mucosal neutrophil counts in neutropenia patients
10/20/2005WO2005098017A1 Method for production of peptide banks
10/20/2005WO2005097996A1 Novel mite allergen
10/20/2005WO2005097989A1 Method of detecting and quantifying wheat endogenous dna sequence
10/20/2005WO2005097970A1 Protein chip having immobilized ubiquitin-conjugating enzymes
10/20/2005WO2005097968A1 Microbe detector and method of microbe detection
10/20/2005WO2005097844A1 Polymer particle
10/20/2005WO2005097828A2 Peptides of cav2.2 that inhibit pain
10/20/2005WO2005097822A1 Identification of the precise amino acid sequence of the epitope recognized by the potent neutralizing human anti-hiv-1 monoclonal antibody igg1b12
10/20/2005WO2005097818A2 An assay system for screening protease inhibitors
10/20/2005WO2005097421A2 Methods for identifying risk of osteoarthritis and treatments thereof
10/20/2005WO2005097328A1 Meat processing machine comprising a fat analyzing device
10/20/2005WO2005097204A1 Preventives/remedies for cancer
10/20/2005WO2005097189A1 Carcinoma cell-specific apoptosis inducing agent targeting gene relevant to chromosome stabilization
10/20/2005WO2005096811A2 In vivo bioassay for gonadotropins
10/20/2005WO2005096810A1 Nonhuman transgenic animal as type 2 diabetes model
10/20/2005WO2005096779A2 Clot retainer
10/20/2005WO2005096706A2 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
10/20/2005WO2005084534A8 Personal diagnostic devices and related methods
10/20/2005WO2005083431A3 Binding agents
10/20/2005WO2005083423A3 System and method for integrating fluids and reagents in self-contained cartridges containing particle and membrane sensor elements
10/20/2005WO2005074969A3 Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a1 (nr4a1)
10/20/2005WO2005073720A3 Method of screening for new drugs
10/20/2005WO2005068647A3 Methods for detecting bacterial pathogens
10/20/2005WO2005057176A3 Method for identification of enzymes
10/20/2005WO2005054864A3 Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 1 (kcnk1)
10/20/2005WO2005054853A3 Method for diagnosing diseases based on levels of anti-glycan antibodies
10/20/2005WO2005047882A3 Multi-dimensional electrophoresis apparatus
10/20/2005WO2005045205A3 Combinatorial lubricating oil composition libraries
10/20/2005WO2005041901A3 Therapeutics using somatostatin agonists
10/20/2005WO2005037229A3 Methods and compositions for modulating gamete adhesion
10/20/2005WO2005030040A8 Hematopoietic stem cell identification and isolation
10/20/2005WO2005020794A3 Taxane chemosensitivity prediction test
10/20/2005WO2005019803A3 Measuring analytes from an electromagnetic spectrum using a wavelength router
10/20/2005WO2005017485A3 Multiplex enzyme-linked immunosorbent assay for detecting multiple analytes
10/20/2005WO2005015202A9 Method and device for measuring the strip mass and/or variations in the strip mass of a running fiber assembly and spinning preparation machine equipped with a measuring device
10/20/2005WO2005007198A3 Design of disease specific agents for diagnostics and therapeutics based on the protein isoform of vegf, her-2, psa
10/20/2005WO2005004798A3 Methods for treating lentivirus infections
10/20/2005WO2004112575A3 Gene amplification and overexpression in cancer
10/20/2005WO2004106886A8 Methods for detecting b. anthracis infection
10/20/2005WO2004102154A3 Systems and methods for measuring fluid properties
10/20/2005WO2004090544A3 Detection, characterization and treatment of viral infection and methods thereof
10/20/2005WO2004086021A8 Apparatus for analyzing mixtures of gases
10/20/2005WO2004081186A3 Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof
10/20/2005WO2004070380A8 Method for the detection of carbon monoxide in a hydrogen-rich gas stream
10/20/2005WO2004064785A3 Cancer therapy sensitizer
10/20/2005WO2004036172A3 Bioweapon-detecting fibrous-network products and methods for making same
10/20/2005WO2002097033A3 Antibodies that immunospecifically bind to trail receptors
10/20/2005US20050235365 Helicokinin-receptor from insects
10/20/2005US20050235274 Real time data integration for inventory management
10/20/2005US20050234969 Services oriented architecture for handling metadata in a data integration platform
10/20/2005US20050234661 Algorithm for estimation of multiple faults on a transmission line or waveguide
10/20/2005US20050234658 Semiconductor wafer inspection system
10/20/2005US20050234655 System and method for securing genomic information
10/20/2005US20050234654 Detection of evolutionary bottlenecking by dna sequencing as a method to discover genes of value
10/20/2005US20050234653 Systems and computer software products for gene expression analysis
10/20/2005US20050234651 Method for analyzing structure of glycoprotein
10/20/2005US20050234650 Method and system for normalization of microarray data
10/20/2005US20050234311 Diagnostic support system for diabetes and storage medium
10/20/2005US20050234227 Ribosome structure and protein synthesis inhibitors
10/20/2005US20050234226 Persephin and related growth factors
10/20/2005US20050234224 Enhanced precipitation and analysis of cryoglobulins
10/20/2005US20050234223 Drug candidate compounds such as H3 receptor inverse agonists can be screened more easily and efficiently
10/20/2005US20050234094 Inhibition of protein kinases with piridinylimidazoles
10/20/2005US20050234078 Assay method for achieving a range of 6-thioguanine in a subject: determining a level of 6-thioguanine and recommending that a subsequent dose be increased
10/20/2005US20050234051 5-Substituted 2-aryl-4 pyrimidinones
10/20/2005US20050234008 Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
10/20/2005US20050234001 Methods and compositions for modulating gluconeogenesis using PGC-1
10/20/2005US20050233991 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
10/20/2005US20050233985 Rsk inhibitors and therapeutic uses thereof
10/20/2005US20050233960 Methods and compositions for inhibiting c-met dimerization and activation
10/20/2005US20050233957 Sodium channel regulators and modulators
10/20/2005US20050233956 Proteins involved in the regulation of energy homeostasis